Sustained Suppression of Ischemic Complications of Coronary Intervention by Platelet GP IIb/IIIa Blockade With Abciximab : One-Year Outcome in the EPILOG Trial

Circulation - United States
doi 10.1161/01.cir.99.15.1951

Related search